《大行報告》大摩降領展(00823.HK)評級至「與大市同步」 目標價下調至71元
大摩發表報告指,考慮到十年期美債孳息率飆升和香港確診宗數上升帶來的負面影響,將領展(00823.HK)評級由「增持」降至「與大市同步」,目標價由78元下調至71元。
大摩指,過去三個月領展股價回升,跑嬴恆指11%,反映了香港零售業在放寬社交距離措施和發放消費券下得以復甦,並預計中港通關前領展業務仍會保持韌性。
不過,大摩指,十年期美債孳息率已飆升至3.3%,因通脹數據較預期強勁,並可能更長時間內保持在高位。目前領展每基金單位分派回報與十年期美債的息差已收窄至1.4%,較長期平均值低1個標準差。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.